fbpx
Endari approved for Sickle Cell the 2nd Drug in nearly 20 years

Endari approved for Sickle Cell the 2nd Drug in nearly 20 years

By August 6, 2018Uncategorized
Endari approved for Sickle Cell the 2nd Drug in nearly 20 years

Endari approved for Sickle Cell the 2nd Drug in nearly 20 years

By August 6, 2018Uncategorized
TOVA Community Health
Sickle Cell Specialty Center
213 Greenhill Ave., Suite B
Wilmington, DE 19805
(302) 429-5870 ext. 120
www.tovacommunityhealth.org

TOVA Community Health
Sickle Cell Specialty Center
213 Greenhill Ave., Suite B
Wilmington, DE 19805
(302) 429-5870 ext. 120
www.tovacommunityhealth.org

Leave a Reply